- Home
- Applications
- metabolic and endocrine diseases
Show results for
Refine by
Metabolic And Endocrine Diseases Product Applications
5 applications found
The endocrine and metabolic system includes endocrine glands and endocrine tissues, which regulate human function by secreting hormones. Endocrine diseases are rare and often very difficult to diagnose and treat. Among the 121 rare diseases included on China’s national list of rare diseases in 2018, more than 20 are ...
ByRareStone Group based in Shanghai, CHINA
Lysosomal diseases are a group of rare, genetic metabolic diseases in which cellular waste products build up in the body. These disorders are generally progressive and there is no cure. Many lysosomal diseases have no FDA-approved ...
ByEli Lilly and Company based in Indianapolis, INDIANA (USA)
Rare neurological diseases include developmental defects of the nervous system, genetic and metabolic diseases, neuroimmune diseases, neurological tumors, special types of infectious diseases of the nervous system, neurodegenerative diseases, and neuromuscular diseases. At present, more than 7,000 rare diseases have been found in humans, about 60% of which are neurological ...
ByRareStone Group based in Shanghai, CHINA
Velacur can also be used to assess and manage other chronic liver diseases, resulting from viral infections, autoimmune disorders, metabolic diseases or excessive alcohol consumption. Like fatty liver disease, viral and autoimmune hepatitis are “silent” diseases of the liver. They show no symptoms until your liver is severely damaged, making it vital for early disease detection to limit progression and protect the health of your ...
BySonic Incytes Medical Corp. based in Vancouver, BRITISH COLUMBIA (CANADA)
Fractyl Health was founded in 2011 with a dedication to developing novel therapeutic interventions that have the potential to help reverse the metabolic disease epidemic. Despite advances in treatment over the past 50 years, metabolic diseases in general, and type 2 diabetes (T2D) in particular, continue to be a principal and rapidly growing driver of morbidity and mortality in the 21st century. Our goal is to transform T2D treatment from chronic blood glucose management to disease-modifying therapies that target ...
ByFractyl Health based in Lexington, MASSACHUSETTS (USA)